Brief: Helius Medical Technologies Sees Q4 Revenue Up More Than 30 Percent

Solana

26/01/2022 22:49

Jan 26 (Reuters) - Helius Medical Technologies Inc  HSDT.O :
    * SEES Q4 REVENUE $250,000 TO $260,000
    * SEES Q4 REVENUE UP MORE THAN 30 PERCENT
    * SEES INITIATION OF PIVOTAL CLINICAL TRIAL IN STROKE
PATIENTS IN
FIRST HALF OF 2022
    * UNAUDITED YEAR END CASH BALANCE OF $11 MILLION
    * Q4 REVENUE VIEW $110000.00 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX58Qmmw 
Further company coverage:  HSDT.O 

 ((Reuters.Briefs@thomsonreuters.com;))